Hubbry Logo
AntacidAntacidMain
Open search
Antacid
Community hub
Antacid
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Antacid
Antacid
Antacid
View on Wikipedia
from Wikipedia

Calcium carbonate antacid tablets

An antacid is a substance which neutralizes stomach acidity and is used to relieve heartburn, indigestion, or an upset stomach.[1] Some antacids have been used in the treatment of constipation and diarrhea.[2] Marketed antacids contain salts of aluminium, calcium, magnesium, or sodium.[2] Some preparations contain a combination of two salts, such as magnesium carbonate and aluminium hydroxide (e.g., hydrotalcite).[3]

Medical uses

[edit]

Antacids are available over the counter and are taken by mouth to quickly relieve occasional heartburn, the major symptom of gastroesophageal reflux disease and indigestion. Treatment with antacids alone is symptomatic and only justified for minor symptoms.[4] Alternative uses for antacids include constipation, diarrhea, hyperphosphatemia, and urinary alkalization.[2] Some antacids are also used as an adjunct to pancreatic enzyme replacement therapy in the treatment of pancreatic insufficiency.[5]

Non-particulate antacids (sodium citrate) increase gastric pH with little or no effect on gastric volume, and therefore may see some limited use in pre-operative procedures. Sodium citrate should be given within one hour of surgery to be the most effective.[6]

Side effects

[edit]

Conventional effervescent tablets contain a significant amount of sodium and are associated with increased risk of adverse cardiovascular events according to a 2013 study.[7] Alternative sodium-free formulations containing magnesium salts may cause diarrhea, whereas those containing calcium or aluminium may cause constipation.[8]: Table 2  Long-term use of antacids containing aluminium may increase the risk of developing osteoporosis.[9] In vitro studies have found a potential for acid rebound to occur due to antacid overuse, however the significance of this finding has been called into question.[10][11]

Properties of antacids

[edit]

When an excess amount of acid is produced in the stomach, the natural mucous barrier that protects the lining of the stomach can degrade, leading to pain and irritation.[12] There is also potential for the development of acid reflux, which can cause pain and damage to the esophagus.[13] Antacids contain alkaline ions that chemically neutralize stomach gastric acid, reducing damage to the stomach lining and esophagus, and relieving pain.[1] Some antacids also inhibit pepsin, an enzyme that can damage the esophagus in acid reflux.[2][14]

Antacids do not directly inhibit acid secretion, and thus are distinct from acid-reducing drugs like H2-receptor antagonists or proton pump inhibitors.[4] Antacids do not kill the bacterium, Helicobacter pylori, which causes most ulcers.[4]

Types

[edit]

Antacids are mainly classified into two categories:

Interactions

[edit]
Structural depiction of tetracycline metal chelation, where 'M' is a metal such as those found in antacids

Antacids are known to interact with several oral medications, including fluoroquinolone and tetracycline antibiotics, iron, itraconazole, and prednisone.[16] Metal chelation is responsible for some of these interactions (e.g. fluoroquinolones, tetracyclines), leading to decreased absorption of the chelated drug. Some interactions may be due to the pH increase observed in the stomach following antacid ingestion, leading to increased absorption of weak acids, and decreased absorption of weak bases.[citation needed] Antacids also cause an increase in pH of the urine (alkalization), which may cause increased blood concentrations of weak bases, and increased excretion of weak acids.[17]

A proposed method to mitigate the effects of stomach acidity and chelation on drug absorption is to space out the administration of antacids with interacting medications by at least two hours,[18] however this method has not been well studied for drugs affected by urine alkalization.[16]

There are concerns regarding interactions between delayed-release tablets and antacids, as antacids may increase the stomach pH to a point at which the coating of the delayed-release tablet will dissolve, leading to degradation of the drug if it is pH sensitive.[17]

Formulations

[edit]

Antacids may be formulated with other active ingredients such as simethicone to control gas, or alginic acid to act as a physical barrier to acid.[19]

Liquids

[edit]
A bottle of liquid antacid containing bismuth subsalicylate as the active ingredient

Several liquid antacid preparations are marketed. Common liquid preparations include milk of magnesia and magnesium/aluminium combinations. A potential advantage of using a liquid preparation over a tablet is that liquids may provide quicker relief, however this may coincide with a shorter duration of action.[20]

Tablets

[edit]

Chewable tablets

[edit]

Chewable tablets are one of the most common forms of antacids, most frequently made from carbonate or hydroxide salts, and are readily available over the counter. Upon reaching the stomach, the powdered antacid salts bind to hydronium (H+) ions, producing chloride salts, carbon dioxide, and water. This process reduces the concentration of H+ ions in the stomach, raising the pH and neutralizing the acid.[8]: Figure 1  Common carbonate salts available in tablet form include those of calcium, magnesium, aluminium, and sodium.[16]

Some common American brands are Tums, Gaviscon chewable tablets, and Maalox chewable tablets.[21]

Effervescent tablets

[edit]

Effervescent tablets are tablets which are designed to dissolve in water, and then release carbon dioxide.[22][23][24] Common ingredients include citric acid and sodium bicarbonate, which react when in contact with water to produce carbon dioxide. Effervescent antacids may also contain aspirin,[25] sodium carbonate, or tartaric acid.[26] Those containing aspirin may cause further gastric irritation and ulceration due to aspirin's effects on the mucous membrane of the stomach.[27]

Brand names

[edit]

Some brands include Alka-Seltzer, Gaviscon, Tums, Gelusil and Eno.[28][29][30]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Antacid

View on Grokipedia
from Grokipedia
An antacid is an over-the-counter that neutralizes excess to provide rapid symptomatic relief from conditions such as , acid indigestion, and upset . These preparations typically consist of basic compounds, including salts of aluminum, calcium, magnesium, or sodium, which react with in the gastric environment to form water and a salt. By elevating the pH of contents, antacids alleviate discomfort associated with (GERD), hyperacidity, and related symptoms without addressing underlying causes. Antacids have a long history in medical practice, dating back over a century, and were originally a primary treatment for before the advent of acid-suppressing therapies like inhibitors. In the , regimens such as the Sippy protocol—combining milk, bicarbonate, and calcium—marked early widespread use for ulcer management, though they carried risks like from excessive intake. Today, antacids are widely available in forms like tablets, liquids, and chewables, with common examples including aluminum hydroxide for constipation-prone users, magnesium hydroxide for those needing a effect, (e.g., ), and combinations like or to balance side effects. While generally safe for short-term use, antacids can cause side effects depending on their composition: magnesium-based ones may lead to , aluminum-based to , and calcium-based to gas or . Chronic or high-dose consumption risks acid rebound, imbalances, or interactions with other drugs, such as reduced absorption of antibiotics like tetracyclines. Users with issues or those taking multiple medications should consult a healthcare provider before regular use.

Overview and Pharmacology

Definition and Composition

Antacids are over-the-counter medications designed to neutralize excess stomach acid, thereby alleviating symptoms associated with hyperacidity such as and . These formulations primarily consist of basic compounds that react with (HCl) in gastric juice to raise the and provide symptomatic relief. The primary active ingredients in antacids include aluminum hydroxide (Al(OH)3), (Mg(OH)2), (CaCO3), and (NaHCO3). These compounds function through acid-base neutralization reactions; for example, reacts with HCl as follows:
\ceCaCO3+2HCl−>CaCl2+H2O+CO2\ce{CaCO3 + 2HCl -> CaCl2 + H2O + CO2}
This reaction produces water, salt, and gas, effectively reducing acidity. Similar reactions occur with the other ingredients, where hydroxides or bicarbonates donate bases to counter the acid. Commercial antacid products also incorporate inactive ingredients to enhance stability, palatability, and manufacturability, such as binders (e.g., ), flavors, sweeteners (e.g., dextrose or ), and colorants (e.g., FD&C dyes). The development of antacids traces back to ancient natural remedies, including the use of mixed with milk and for digestive relief, as documented in clay tablets from the Sumerians. Over time, these evolved into modern synthetic formulations in the 19th and 20th centuries, incorporating refined salts and combinations for improved efficacy and convenience.

Mechanism of Action

Antacids primarily exert their effects through a chemical neutralization reaction with (HCl) in the gastric juice, elevating the stomach's from its typical acidic range of 1.5 to 3.5 to a less acidic, near-neutral level of about 4 to 5. This process reduces the concentration of free hydrogen ions (H⁺), thereby alleviating the corrosive impact of excess acidity on the . The reaction typically produces and an ionic salt, with some formulations also generating (CO₂) gas as a , which can lead to belching. For instance, , a common antacid base, undergoes the following neutralization: Mg(OH)2+2HCl→MgCl2+2H2O\mathrm{Mg(OH)_2 + 2HCl \rightarrow MgCl_2 + 2H_2O} This equation illustrates the stoichiometric balance where two hydroxide ions (OH⁻) from the antacid bind with two H⁺ ions from HCl to form water, leaving magnesium chloride as the salt. The onset of this neutralizing action is rapid, often achieving a increase above 3.0 within seconds to minutes after administration, owing to the immediate ionic interactions in the aqueous gastric environment. However, the duration of effect remains limited to approximately 1 to 2 hours, primarily because the continuously secretes new HCl, and the neutralized is propelled into the via gastric emptying, allowing re-acidification. Antacids like aluminum or magnesium compounds demonstrate this short-lived buffering due to their reliance on local reactivity rather than sustained inhibition of acid production. In terms of , most antacids exhibit minimal to no systemic absorption, confining their therapeutic action to the luminal surface of the and proximal . This localized mechanism avoids widespread physiological effects but underscores the need for frequent dosing to maintain elevation. Variations in acid-binding capacity, quantified as acid neutralizing capacity (ANC), further differentiate antacids; , for example, offers high ANC due to its potent reactivity but releases CO₂ gas during neutralization, potentially causing : CaCO3+2HCl→CaCl2+H2O+CO2\mathrm{CaCO_3 + 2HCl \rightarrow CaCl_2 + H_2O + CO_2} In contrast, non-carbonate bases like magnesium hydroxide provide effective neutralization without gas formation, though their overall capacity may be lower per unit dose.

Therapeutic Applications

Medical Indications

Antacids are primarily indicated for the symptomatic relief of heartburn and acid indigestion, which are common manifestations of excess gastric acid production. They are also recommended for managing gastroesophageal reflux disease (GERD), where they alleviate symptoms such as regurgitation and epigastric discomfort by neutralizing stomach acid. In addition, antacids provide relief for dyspepsia, often characterized by upper abdominal pain or bloating after meals. For peptic ulcers, antacids are used to prevent acid-related damage to the gastric or duodenal mucosa, particularly as an adjunct to other therapies during the healing process. The 2022 American College of Gastroenterology guidelines recommend empiric inhibitors as first-line therapy for patients with uncomplicated GERD symptoms but suggest antacids or alginates for on-demand relief of occasional or as initial therapy in alongside modifications. Antacids offer short-term relief for sporadic symptoms but serve an adjunctive role in chronic conditions like , where they address breakthrough acidity alongside primary treatments. Beyond gastrointestinal applications, certain antacids, such as those containing aluminum hydroxide, are occasionally used off-label in mouthwashes to soothe oral induced by or . Phosphate-binding antacids, including aluminum- and calcium-based formulations, are employed off-label to manage in patients with by reducing dietary phosphate absorption.

Clinical Efficacy and Limitations

Antacids demonstrate clinical efficacy in providing rapid symptomatic relief for mild and acid indigestion, with typically occurring within 5 minutes of administration. Studies indicate that antacids effectively neutralize , leading to significant reductions in heartburn intensity and frequency, as evidenced by patient-reported outcomes in randomized controlled trials. For instance, a review of clinical data highlights antacids' ability to alleviate symptoms associated with (GERD) in the short term, supporting their role in immediate relief for episodic use. Despite this, antacids have notable limitations in their therapeutic scope and duration. Their acid-neutralizing effect is short-lived, generally lasting 20 to before gastric returns to baseline due to ongoing acid secretion. They are ineffective as standalone treatments for severe GERD or peptic ulcers, where structural or erosive damage requires acid suppression therapies like inhibitors (PPIs) or H2-receptor antagonists; antacids are better positioned as adjunctive agents for breakthrough symptoms. Additionally, prolonged or high-dose use can induce rebound hyperacidity, characterized by increased production upon cessation, particularly with calcium- or sodium-based formulations. Several factors influence antacid , including optimal dosing relative to meals and inter-individual differences in gastric . Administration approximately 1 hour after eating or at symptom onset maximizes neutralization by coinciding with peak acid load, while taking them with food may dilute their effect. Variability in baseline gastric pH among patients can alter response rates, with lower starting pH potentially requiring higher doses for comparable relief. Compared to acid-suppressant medications such as PPIs and H2 blockers, antacids excel in speed of onset for acute relief but offer inferior duration of action, making them suitable for on-demand use rather than maintenance therapy.

Classification

Active Ingredients

Antacids employ various active ingredients, primarily salts of aluminum, magnesium, calcium, and , to neutralize excess through chemical reactions that raise the stomach's . These agents differ in their onset of action, duration of effect, and physiological impacts, influencing their suitability for specific patient needs. Aluminum-based compounds, such as aluminum hydroxide (Al(OH)_3), provide a relatively slow , typically taking longer to elevate compared to faster-acting alternatives like magnesium salts. This compound neutralizes acid by forming aluminum chloride and water, but it is associated with constipating effects proportional to the dose, particularly in elderly patients. Additionally, aluminum hydroxide serves as a in the , making it valuable for managing in renal patients. Magnesium-based antacids, including (Mg(OH)_2) and magnesium carbonate (MgCO_3), exhibit a rapid onset of action, often raising gastric within minutes, which contributes to their quick relief of symptoms like . These agents react with to produce and water, offering effective but sometimes short-lived neutralization. A notable property is their laxative effect, which can alleviate in some users but may cause with overuse. In individuals with impaired kidney function, magnesium-based antacids pose a risk of due to reduced renal excretion of the absorbed magnesium ions. Calcium-based antacids, such as (CaCO_3), are characterized by high neutralizing capacity per dose, rapidly neutralizing gastric acid and allowing for potent acid reduction in a relatively small volume. The reaction with yields , , and , with the released gas often leading to or . While effective for short-term use, prolonged or high-dose intake can result in hypercalcemia from excessive calcium absorption or contribute to , a condition involving hypercalcemia, renal impairment, and . Calcium carbonate is particularly safe for kidneys, including in patients with chronic kidney disease (CKD), where it neutralizes acid quickly and serves as a phosphate binder to help manage hyperphosphatemia, unlike magnesium- or aluminum-based antacids which can accumulate and cause toxicity in individuals with reduced kidney function. Sodium-based antacids, primarily (NaHCO_3), deliver the most rapid onset of action among traditional agents, quickly buffering acid to produce , water, and . However, this effect is short-lived, often lasting only 30-60 minutes due to rapid expulsion of the generated gas and systemic absorption. The significant sodium content raises concerns for patients with or fluid retention, as it can exacerbate elevation or contribute to cardiovascular risks with chronic use. While the core antacids rely on these neutralizing salts, some formulations incorporate adjuncts like alginates for barrier protection against , though pure antacids emphasize the acid-neutralizing properties of the above ingredients.

Combination Formulations

Combination antacids incorporate multiple active ingredients to achieve synergistic effects, such as balancing gastrointestinal side effects while providing effective acid neutralization. The most prevalent combinations involve aluminum hydroxide and , where aluminum's tendency to cause is counteracted by magnesium's properties, resulting in minimal net impact on bowel function when formulated in appropriate ratios. provides rapid pH elevation in the , while aluminum hydroxide offers prolonged acid-binding capacity, extending the overall duration of relief compared to single-agent formulations. Calcium carbonate and magnesium hydroxide represent another common pairing, aimed at broader acid neutralization with reduced risk of hypercalcemia from excessive calcium alone; this blend enhances tolerability for frequent users by mitigating magnesium's potential for through controlled dosing. These combinations improve patient adherence by minimizing adverse effects like altered bowel habits, which are more pronounced with isolated ingredients, and support better symptom control across varying loads. Further enhancements include integrating simethicone with aluminum-magnesium bases to address concomitant gas and bloating, as simethicone disperses in the without interfering with neutralization. Similarly, formulations blending antacids with alginates create a protective that floats on gastric contents to prevent , particularly beneficial for esophageal irritation beyond simple neutralization. The development of these multi-ingredient antacids gained prominence in the , coinciding with regulatory advancements in over-the-counter formulations and a push for improved and compliance prior to the widespread adoption of histamine-2 receptor antagonists. This era marked a shift from predominantly single-component products to balanced combinations, reflecting clinical observations of better outcomes in managing dyspepsia and .

Dosage Forms

Liquid Preparations

Liquid antacids are typically formulated as aqueous suspensions or solutions containing active ingredients such as aluminum hydroxide, , or , often combined to balance neutralizing capacity and side effects. These preparations may include thickening agents, such as alginates or gums, to enhance esophageal coating and prolong contact with the mucosa. For instance, common products like consist of a suspension of aluminum hydroxide and in water, providing a milky consistency that aids in uniform distribution upon administration. The primary advantages of liquid antacids include more rapid onset of action, often within minutes, compared to solid forms such as tablets or pills, as they do not need to dissolve and are immediately available for neutralization in the . Liquid forms generally provide faster relief than tablets or pills, with overall effectiveness being similar between forms. Some older studies suggest that liquids may have higher acid-neutralizing capacity. This faster relief—typically 30-35 minutes for pH elevation in the —makes them suitable for acute symptoms. Additionally, they are easier to swallow for individuals with or those who have difficulty chewing tablets, and they allow for precise dosing using measuring spoons or cups, facilitating tailored administration for children or the elderly. Despite these benefits, liquid antacids have drawbacks, including a shorter owing to the risk of microbial spoilage and physical instability in suspensions. Some formulations, particularly those with , contain high sodium levels (up to over 60 mmol/L in certain products), which may be problematic for patients on sodium-restricted diets. Administration can also be messier, as spills or residue may occur during pouring or measurement. For optimal use, antacids should be vigorously shaken before each dose to resuspend settled particles and ensure consistent potency. They are best stored at , away from freezing conditions to prevent separation into layers, and in upright positions to minimize settling during storage.

Solid Preparations

preparations of antacids primarily consist of tablets and powders, offering convenient alternatives to liquid forms for neutralizing . These forms are widely used due to their ease of handling and storage, making them suitable for on-the-go administration. Tablets dominate the solid antacid market, available in various subtypes tailored to different needs and administration methods. Common types include chewable tablets, effervescent tablets, and plain tablets. Chewable tablets, often formulated with calcium-based compounds like , are designed for mastication to facilitate rapid disintegration and acid neutralization in the and . Effervescent tablets dissolve in to produce fizz, enhancing palatability and ensuring complete dissolution for quick action; they typically incorporate antacid salts such as or . Plain tablets, in contrast, are swallowed whole and disintegrate in the , providing a straightforward option for standard relief without additional processing. Powder forms, less common but still utilized, involve mixing antacid ingredients into a dispersible dry blend that can be stirred into or taken directly for immediate effect. These solid preparations offer several advantages over liquid antacids, including superior portability for travel or daily carry, extended due to reduced moisture content, and precise dosing through pre-measured units. Powders and tablets generally maintain stability for 2-3 years under proper storage, outperforming liquids in longevity. However, liquid forms generally provide faster relief because they are already in solution and do not require disintegration or dissolution, whereas solid forms must first disintegrate and dissolve before neutralizing acid. Overall, the effectiveness of solid and liquid antacids in relieving symptoms is similar. Manufacturing of solid antacids typically involves compression of powdered active ingredients with excipients to form tablets. For plain and chewable tablets, direct compression mixes antacids like aluminum hydroxide or magnesium carbonate with binders (e.g., ), lubricants (e.g., ), and disintegrants, followed by high-pressure to achieve uniform hardness. Effervescent tablets require a two-stage process: blending acid sources (e.g., ) with base components (e.g., ) under low-humidity conditions to prevent premature reaction, then compressing the granulate into tablets that effervesce upon water contact. Powders are prepared by simple blending of antacid salts with flavorings and sweeteners, often granulated for better flow. Administration emphasizes proper technique for optimal . For chewable tablets, thorough mastication is essential to increase surface area and accelerate the neutralization reaction, typically dosing 1-2 tablets three to four times daily as needed. Effervescent tablets should be fully dissolved in before consumption to release CO2 and ensure even distribution. Plain tablets are taken with , while powders are mixed into liquid; general dosing for calcium-based solids is 1-4 tablets daily, not exceeding 8000 mg (approximately 3200 mg elemental calcium). Patients are advised to consult healthcare providers for prolonged use.

Safety Considerations

Adverse Effects

Antacids are generally well-tolerated when used occasionally and in recommended doses, but they can cause various adverse effects depending on the active ingredient and duration of use. Common gastrointestinal side effects include constipation associated with aluminum-based antacids, such as aluminum hydroxide, due to its binding properties in the intestine. In contrast, magnesium-containing antacids, like magnesium hydroxide, often lead to diarrhea from their osmotic effects. Calcium carbonate and sodium bicarbonate formulations may cause belching and flatulence as a result of carbon dioxide release during acid neutralization. Overuse of absorbable antacids, particularly sodium bicarbonate, can result in metabolic alkalosis, characterized by elevated blood pH and potential electrolyte imbalances. Serious adverse effects are less frequent but can occur with excessive or prolonged intake. Calcium-based antacids may lead to hypercalcemia, especially in high doses, and in severe cases, contribute to , involving hypercalcemia, , and renal impairment. is a risk with magnesium antacids in patients with renal impairment, potentially causing , , and cardiac arrhythmias. Long-term use of aluminum antacids has been linked to , which can result in bone softening and rickets-like symptoms due to phosphate binding in the gut. In patients with renal impairment, aluminum accumulation from long-term use can also cause , , and . Rare adverse effects encompass allergic reactions, such as or to specific components, though these are uncommon with standard formulations. Liquid antacid preparations carry a small of aspiration, particularly in individuals with impaired or when taken while recumbent. Risk factors for adverse effects include chronic use exceeding two weeks and underlying comorbidities such as , which impairs clearance of aluminum, magnesium, or calcium. In patients with chronic kidney disease (CKD), calcium carbonate antacids are generally safer than those containing magnesium or aluminum, as they neutralize stomach acid quickly—often within seconds to minutes—and do not accumulate in the body to the same extent, while also aiding in phosphorus management by binding dietary phosphate to prevent absorption. In contrast, magnesium and aluminum can build up in impaired renal function, leading to toxicity such as hypermagnesemia or aluminum-related encephalopathy. Guidelines recommend limiting antacid use to no more than two weeks at maximum dosage without medical supervision to minimize these risks. For persistent symptoms, consultation with a healthcare provider is advised.

Drug Interactions

Antacids primarily interact with other medications through pharmacokinetic mechanisms, such as with multivalent cations (e.g., aluminum, magnesium, calcium) or alterations in gastrointestinal that affect drug dissolution and absorption. These interactions often reduce the of concurrently administered drugs, particularly when taken simultaneously. For instance, antacids bind to tetracyclines and fluoroquinolones, forming insoluble complexes that impede their absorption; clinical guidelines recommend separating doses by at least 2 hours to minimize this effect. Similar reductions in absorption occur with oral iron supplements and , where cation or elevated hinders uptake, potentially requiring dose adjustments or timing separations. Pharmacodynamic interactions arise from the additive acid-neutralizing effects of antacids when combined with other gastric acid suppressants, such as H2-receptor antagonists or inhibitors (PPIs), leading to enhanced elevation of intragastric . This potentiation can be beneficial for symptom relief but may antagonize therapies reliant on gastric acidity, such as certain eradication regimens involving PPIs, where excessive pH neutralization could impair efficacy. In , such combinations necessitate careful monitoring to balance acid suppression without compromising treatment outcomes. Food-related interactions with antacids include binding to dietary components, notably , where aluminum- or calcium-containing formulations form insoluble complexes that reduce absorption and may contribute to during prolonged use. Dairy products can enhance calcium absorption from calcium-based antacids but may concurrently diminish the antacid's neutralizing capacity due to competing buffering effects. Specific examples highlight these risks: antacids markedly decrease by neutralizing the acidic environment required for its solubility and absorption, warranting a 2-hour dosing interval. Magnesium-containing antacids can decrease the absorption of , potentially leading to subtherapeutic levels; serum level monitoring is recommended, especially in patients with renal impairment.

Availability and Regulation

Common Brand Names

In the United States, several prominent antacid brands are widely available over-the-counter, often formulated with , aluminum hydroxide, , or combinations thereof. , primarily containing , is a chewable tablet brand that neutralizes stomach acid quickly. combines and for relief from and . features aluminum hydroxide and in liquid or tablet form to balance acid reduction without excessive or . , similar to , includes aluminum hydroxide, , and simethicone to address both acid and gas-related symptoms. Pepto-Bismol, with , provides antacid-like effects alongside anti-diarrheal and benefits for upset stomach. Internationally, antacid brands vary by region but often emphasize similar active ingredients with added protective agents. In the and , Gaviscon is a leading option, incorporating aluminum hydroxide, , and sodium alginate to form a barrier against . , popular in multiple countries including the US, UK, and , uses and for effervescent action, sometimes combined with aspirin for broader pain relief. Rennie, common in the UK and , relies on and magnesium carbonate in chewable tablets. Generic antacids have been widely available since the 1980s, following the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Act), which streamlined FDA approval for generic versions of approved drugs, including over-the-counter antacids, leading to increased market competition and affordability.

Over-the-Counter Status

Most antacids are classified as over-the-counter (OTC) medications , deemed and effective (GRASE) for self-use by the (FDA) under the Antacid Products for Over-the-Counter Human Use (21 CFR part 331), established through rulemaking finalized in 1977 following proposals in the early 1970s. This classification applies to low-dose formulations containing active ingredients such as , , and aluminum hydroxide, allowing consumers to purchase and use them without a prescription for short-term relief of and indigestion. Certain antacids require a prescription, particularly high-dose formulations used for phosphate binding in patients with (CKD), such as calcium acetate or elevated doses of to manage in end-stage renal disease. Compounded antacid preparations tailored for specific medical needs may also necessitate prescription oversight to ensure appropriate dosing and monitoring. In the , antacids are typically available as non-prescription medicines under the oversight of the (EMA) and national authorities, aligning with Directive 2001/83/EC, which governs OTC status for safe, products. Global availability varies, with antacids generally OTC in developed regions but subject to stricter controls or prescription requirements in some developing countries due to regulatory and quality assurance differences. OTC antacid labeling includes mandatory warnings and usage guidelines per FDA regulations, such as consulting a healthcare provider before use if (where is not formally categorized but considered Category C for , with reduced dosing recommended, e.g., no more than 6 tablets of 750 mg in 24 hours), for children under 12 years (use only under adult supervision and medical advice due to potential risks), or exceeding maximum daily doses like 8 grams of (equivalent to 160 mEq calcium). These precautions aim to prevent overuse, with instructions limiting maximum dosage to no more than 2 weeks without professional guidance.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK526049/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC8966100/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC3546438/
  4. https://www.fda.gov/drugs/understanding-over-counter-medicines/over-counter-otc-heartburn-treatment
  5. https://www.webmd.com/drugs/2/drug-76860-5123/antacid-oral/aluminum-magnesium-antacid-oral/details
  6. https://www.webmd.com/heartburn-gerd/treating-heartburn-over-counter-medicine
  7. https://genchem.chem.umass.edu/chem110/110_Experiment_3.htm
  8. https://pubchem.ncbi.nlm.nih.gov/compound/Calcium-Carbonate
  9. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=026aefd6-bb80-1ffd-e063-6394a90a1262&type=display
  10. https://afc-ce.com/antacids-awareness-and-appreciation/
  11. https://chem.libretexts.org/Bookshelves/Physical_and_Theoretical_Chemistry_Textbook_Maps/Supplemental_Modules_%28Physical_and_Theoretical_Chemistry%29/Acids_and_Bases/Acid_Base_Reactions/Neutralization
  12. https://www.flinnsci.com/api/library/Download/a4c91d864e3e47f3b213a523ef2d55c4
  13. https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-021-01687-8
  14. https://www.sciencedirect.com/topics/nursing-and-health-professions/antacid-agent
  15. https://f1000research.com/articles/11-1057
  16. https://www.ncbi.nlm.nih.gov/books/NBK554462/
  17. https://gi.org/topics/dyspepsia/
  18. https://journals.lww.com/ajg/fulltext/2022/01000/acg_clinical_guideline_for_the_diagnosis_and.14.aspx
  19. https://www.mayoclinic.org/diseases-conditions/gerd/diagnosis-treatment/drc-20361959
  20. https://www.ncbi.nlm.nih.gov/books/NBK546669/
  21. https://emedicine.medscape.com/article/241185-medication
  22. https://www.nature.com/articles/s41598-025-98558-z
  23. https://iffgd.org/manage-your-health/diet-and-treatments/antacids/
  24. https://medlineplus.gov/ency/patientinstructions/000198.htm
  25. https://my.clevelandclinic.org/health/drugs/23076-antacid
  26. https://www.goodrx.com/conditions/heartburn/otc-heartburn-meds
  27. https://pubchem.ncbi.nlm.nih.gov/compound/Aluminum-Hydroxide
  28. https://www.ncbi.nlm.nih.gov/books/NBK225636/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC7911806/
  30. https://www.ncbi.nlm.nih.gov/books/NBK562303/
  31. https://consultqd.clevelandclinic.org/hyperphosphatemia-in-kidney-disease-how-to-choose-a-phosphorus-binder
  32. https://www.ncbi.nlm.nih.gov/books/NBK559139/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC5500347/
  34. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/aluminum-magnesium-hydroxide
  35. https://www.drugs.com/mtm/calcium-carbonate-and-magnesium-hydroxide.html
  36. https://pubmed.ncbi.nlm.nih.gov/3048455/
  37. https://iffgd.org/wp-content/uploads/520_Antacids.pdf
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC4343538/
  39. https://pubmed.ncbi.nlm.nih.gov/6781389/
  40. https://www.researchgate.net/publication/282244540_Microbial_spoilage_instability_risk_of_antacid_suspension_in_the_presence_of_commonly_used_preservative_system
  41. https://pubmed.ncbi.nlm.nih.gov/1398788/
  42. https://www.em-consulte.com/article/513841/drug-storage-and-stability
  43. https://www.pharmtech.com/view/effervescent-dosage-manufacturing
  44. https://www.researchgate.net/publication/273136692_PREPARATION_AND_IN-VITRO_EVALUATION_OF_ANTACID_TABLET
  45. https://siip.ac.in/wp-content/uploads/2021/04/powders-granules.pdf
  46. https://www.pharmtech.com/view/chewable-tablets-a-review-of-formulation-considerations
  47. https://www.drugs.com/dosage/calcium-carbonate.html
  48. https://www.ncbi.nlm.nih.gov/books/NBK493172/
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC3149864/
  50. https://pmc.ncbi.nlm.nih.gov/articles/PMC3770998/
  51. https://www.ncbi.nlm.nih.gov/books/NBK549811/
  52. https://pubmed.ncbi.nlm.nih.gov/2064842/
  53. https://www.ncbi.nlm.nih.gov/books/NBK609094/
  54. https://pubmed.ncbi.nlm.nih.gov/622629/
  55. https://www.milwaukeenephrologists.net/blog/what-antacids-are-safe-for-kidneys
  56. https://www.bcrenal.ca/resource-gallery/Documents/Non-Prescription_Medications_and_Your_Kidneys.pdf
  57. https://www.mayoclinic.org/drugs-supplements/sodium-bicarbonate-oral-route-intravenous-route-subcutaneous-route/description/drg-20065950
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC3444856/
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC7109143/
  60. https://www.ncbi.nlm.nih.gov/books/NBK557385/
  61. https://ods.od.nih.gov/factsheets/Phosphorus-HealthProfessional/
  62. https://www.ncbi.nlm.nih.gov/books/NBK559221/
  63. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020405s004lbl.pdf
  64. https://www.drugs.com/drug-class/antacids.html
  65. https://www.health.harvard.edu/diseases-and-conditions/over-the-counter-antacids-for-heartburn
  66. https://perks.optum.com/blog/antacid-brands
  67. https://www.nhs.uk/medicines/antacids/
  68. https://www.chemistwarehouse.com.au/shop-online/1052/antacids
  69. https://www.fda.gov/drugs/cder-conversations/40th-anniversary-generic-drug-approval-pathway
  70. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-331
  71. https://www.fda.gov/drugs/historical-status-otc-rulemakings/rulemaking-history-otc-antacid-drug-products
  72. https://www.mayoclinic.org/drugs-supplements/calcium-acetate-oral-route/description/drg-20062494
  73. https://medlineplus.gov/druginfo/meds/a620017.html
  74. https://pmc.ncbi.nlm.nih.gov/articles/PMC5313253/
  75. https://aesgp.eu/otc-medicines
  76. https://www.mdpi.com/2227-9032/9/2/123
  77. https://www.drugs.com/pregnancy/calcium-carbonate.html
  78. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24cdab48-bcc7-e66f-e063-6394a90abbd7
Add your contribution
Related Hubs
User Avatar
No comments yet.